Understanding growth hormone deficiency after a brain injury in adults
Official title: Characterizing Growth Hormone Deficiency in Traumatic Brain Injury: Evaluation of the Growth Hormone in Adult Quality of Life Questionnaire
Run by University of Calgary · NCT07795736 · Data updated 2026-11-12
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Locations | 2 sites (Calgary, Alberta and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | March 1, 2028 |
| Study ends | November 1, 2028 |
| Registry record updated | August 31, 2026 |
| Trial ID | NCT07795736 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18-75 with a diagnosed mild TBI, at least 1 year of persistent symptoms, fluent in English, and referred for suspected GHD.
✕Probably not a fit
Patients without growth hormone deficiency or those not receiving GH replacement will not experience treatment-related benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study observes adults with mild to moderate/severe traumatic brain injury to see how growth hormone deficiency relates to quality of life, fatigue, mood, and sleep. Participants complete baseline questionnaires and undergo provocative testing for GHD. If GHD is diagnosed, some may receive growth hormone replacement and be followed for 12 weeks to assess change in symptoms and quality of life. The study also explores whether a QoL-AGHDA score can help predict GHD and measure treatment response. No experimental interventions are required other than standard clinical testing and observational follow-up.
Why it matters
Potential benefit: If successful, the study could help identify GHD more accurately in brain-injured patients and show whether GH replacement improves symptoms and quality of life.
How similar studies have gone: Prior research has shown that GHD can occur after TBI and that GH testing is variable; this study builds on mixed evidence and is exploratory in nature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: Adults aged 18-70 years must be referred and have a diagnosis of mTBI made by a brain injury specialist physician and meet the 2023 ACRM diagnostic criteria (Appendix A, Panel A) or the NIH diagnostic criteria for moderate/severe TBI (Appendix A, Panel B). All participants must be symptomatic for at least one-year post-injury (determined by the Glasgow Extended Scale score of less than 8 for moderate/severe TBI and a Rivermead Post-Concussion Questionnaire score of \> 13 with 3 or more symptoms scored \> 3 for mTBI), at the time of screening. All participants must also be fluent in English and be able to either complete questionnaires online or over the phone. In terms of concomitant therapies and medication, all prescription and non-prescription medications (e.g., over-the-counter drugs and herbal supplements) and therapies will be recorded by participants during baseline assessments. Participants with GHD on treatment will be asked to disclose any changes in medications/and or therapies at each bi-weekly follow up questionnaires. Exclusion criteria include untreated pituitary deficits to minimize confounding factors (unless treated/consulted with Dr. Debert and/or Dr. Lithgow), other intracranial abnormalities, chronic neurological conditions, untreated medical conditions, major medical conditions in the past 6 months such as stroke, and current or planned pregnancy.
Where it's running
-
University of Calgary
Calgary, Alberta, Canada Recruiting -
Foothills Medical Center, Main Floor Special Services
Calgary, Alberta, Canada Not yet recruiting
Study contacts
- Principal investigator: Chantel T Debert, MD MSc FRCPC CSCN — University of Calgary
- Study coordinator: Chantel T Debert, MD MSc FRCPC CSCN
- Email: cdebert@ucalgary.ca
- Phone: (403) 944-4500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
ZEPU-2000 robotic rehab for arm and leg weakness
This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.
-
ZEPU-SG1PLUS Hand Training with Robotic Rehab for Arm Problems
A small study tests whether adding the ZEPU-SG1PLUS robotic hand trainer to standard rehab is safe and helps people with arm problems after stroke, spinal cord injury, brain injury, or orthopedic injuries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.